Drug:
Reaction: NASOPHARYNGITIS
20260101 - 20261231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 26859885 |
GB |
60 | |
Immunosuppression, Cough, Infection, Nasopharyngitis, Inappropriate schedule of product administration, Product prescribing issue, |
||||
INFLIXIMAB-DYYB, |
||||
| 502 | 26859951 |
US |
82 | 2 |
Blood glucose increased, Nasopharyngitis, Product dose omission issue, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 503 | 26860379 |
US |
64 | 2 |
Nasopharyngitis, Eczema, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 504 | 26860503 |
CA |
66 | 2 |
Arthralgia, Asthma, Condition aggravated, Cough, Dyspepsia, Eructation, Fatigue, Feeling abnormal, Haematochezia, Illness, Inappropriate schedule of product administration, Joint swelling, Large intestine polyp, Lower respiratory tract infection, Nasopharyngitis, Pain in extremity, Peripheral swelling, Pyrexia, Sepsis, Sleep disorder, |
||||
AMLODIPINE, SARILUMAB, SARILUMAB, CITALOPRAM, CITALOPRAM HYDROBROMIDE, FOLIC ACID, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LEFLUNOMIDE, LEVOTHYROXINE SODIUM, |
||||
| 505 | 26860588 |
US |
60 | 1 |
Bacteraemia, Carditis, Nasopharyngitis, White blood cell count decreased, Platelet count decreased, |
||||
DUPILUMAB, DUPILUMAB, CARVEDILOL, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, FOLIC ACID, EMPAGLIFLOZIN, ATORVASTATIN CALCIUM, LISINOPRIL, MOMETASONE FUROATE, MOMETASONE, PANTOPRAZOLE SODIUM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, TADALAFIL, THIAMINE HYDROCHLORIDE, RIBOFLAVIN 5 PHOSPHATE SODIUM, DEXPANTHENOL AND NIACINAMIDE, VITAMIN E, |
||||
| 506 | 26860720 |
US |
2 | |
Sneezing, Cough, Seasonal allergy, Nasopharyngitis, |
||||
TREPROSTINIL, TREPROSTINIL, TREPROSTINIL, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, VITAMIN E, ACETAMINOPHEN, NITROFURANTOIN, NITROFURANTOIN MONOHYDRATE/MACROCRYSTALS, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), FUROSEMIDE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, METOLAZONE, SILDENAFIL CITRATE, SILDENAFIL, LINACLOTIDE, SOTATERCEPT-CSRK, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, PIRFENIDONE, DIPHENHYDRAMINE HYDROCHLORIDE, OXYGEN, 0XYGEN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, FISH OIL, |
||||
| 507 | 26860879 |
CA |
49 | 2 |
Blood pressure systolic decreased, Back pain, Body temperature decreased, Bronchial disorder, Contusion, Decreased immune responsiveness, Discomfort, Erythema nodosum, Feeling hot, Gait disturbance, Gastritis fungal, Hypotension, Needle issue, Influenza, Mood altered, Myocardial infarction, Nasopharyngitis, Oropharyngeal pain, Psychiatric symptom, Stress, Ecchymosis, Rhinorrhoea, Fatigue, Musculoskeletal pain, Dehydration, Neoplasm progression, Carcinoid tumour, Cough, Nausea, Pain, Alopecia, Headache, Heart rate decreased, Diarrhoea, Vomiting, Injection site pain, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, PANTOPRAZOLE, PANTOPRAZOLE, MORPHINE SULFATE, DEXLANSOPRAZOLE, MAGNESIUM, SULFAMETHOXAZOLE AND TRIMETHOPRIM, |
||||
| 508 | 26861170 |
27 | 2 | |
Cough, Nasopharyngitis, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, |
||||
| 509 | 26861203 |
CA |
||
Abnormal clotting factor, Anal erythema, Constipation, Contusion, Cough, Crying, Diarrhoea, Faeces hard, Haemoglobin abnormal, Hepatic enzyme abnormal, Hyperhidrosis, Hyperphagia, Mucous stools, Nasopharyngitis, Pain, Parainfluenza virus infection, Pneumonia, Pollakiuria, Rhinorrhoea, Urine output decreased, Vomiting, Weight fluctuation, Weight increased, Drug ineffective, Incorrect dose administered, |
||||
ENOXAPARIN SODIUM, ENOXAPARIN SODIUM, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, TEDUGLUTIDE, CALCIUM, IRON, LANSOPRAZOLE, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, ERGOCALCIFEROL, |
||||
| 510 | 26861577 |
US |
71 | 2 |
Psoriatic arthropathy, Brain fog, Night sweats, Peripheral nerve operation, Back pain, Nasopharyngitis, Cystitis interstitial, Middle ear effusion, Oropharyngeal pain, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 511 | 26862192 |
US |
58 | 2 |
Neuropathy peripheral, Cataract, Nasopharyngitis, Gout, |
||||
SODIUM OXYBATE, SODIUM OXYBATE, ALLOPURINOL, MELOXICAM, METHYLPREDNISOLONE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 512 | 26862271 |
US |
45 | 2 |
Nasopharyngitis, Flushing, Peripheral coldness, Stress, Paraesthesia, Multiple sclerosis, Nausea, Fatigue, Pruritus, Diarrhoea, Gastrointestinal sounds abnormal, Hot flush, Abdominal discomfort, Alopecia, Headache, Influenza, |
||||
DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, DIROXIMEL FUMARATE, |
||||
| 513 | 26852394 |
US |
48 | 2 |
Dyspnoea, Cough, Dry skin, Nasopharyngitis, Eye pruritus, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 514 | 26852437 |
US |
62 | |
Nasopharyngitis, Illness, Depression, Anxiety, Product dose omission issue, Hypertension, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 515 | 26852582 |
US |
3 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 516 | 26852626 |
US |
44 | 1 |
Infection, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 517 | 26852806 |
75 | 2 | |
Product dose omission issue, Nasopharyngitis, |
||||
LENALIDOMIDE, |
||||
| 518 | 26853151 |
US |
11 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 519 | 26853175 |
US |
60 | 2 |
Nasopharyngitis, Chronic obstructive pulmonary disease, Dyspnoea, Wheezing, Productive cough, |
||||
DUPILUMAB, |
||||
| 520 | 26853182 |
US |
2 | |
Cough, Body temperature increased, Nasopharyngitis, |
||||
DUPILUMAB, ANASTROZOLE, ANASTROZOLE TABLETS, LORATADINE, LORATADINE TABLET, FLUTICASONE PROPIONATE, FLUTICASONE PROPIONATE NASAL, ALENDRONATE SODIUM, HALOBETASOL PROPIONATE, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, SODIUM FLUORIDE, SODIUM FLUORIDE AND POTASSIUM NITRATE, ERGOCALCIFEROL, |
||||
| 521 | 26853355 |
US |
||
Nasopharyngitis, Decreased appetite, Anosmia, Rash, Insomnia, |
||||
TECLISTAMAB-CQYV, |
||||
| 522 | 26853422 |
US |
30 | 2 |
Muscle fatigue, Nasopharyngitis, Asthenia, Sluggishness, |
||||
TIRZEPATIDE, |
||||
| 523 | 26853601 |
US |
83 | 2 |
Nasopharyngitis, Dizziness, Nausea, |
||||
EVOLOCUMAB, |
||||
| 524 | 26854004 |
CA |
30 | |
Colitis, Oropharyngeal pain, Disturbance in attention, Nasal congestion, Brain fog, Headache, Fatigue, Nasopharyngitis, Diarrhoea, Chills, Therapeutic response changed, Off label use, Inappropriate schedule of product administration, Suspected off label use, |
||||
INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, INFLIXIMAB-DYYB, BUDESONIDE, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 525 | 26854035 |
CA |
70 | 1 |
Blood pressure increased, Disease recurrence, Influenza, Malaise, Nasopharyngitis, Psoriasis, Therapeutic product effect decreased, Inappropriate schedule of product administration, |
||||
AMLODIPINE, BRODALUMAB, BRODALUMAB, ALLOPURINOL, |
||||
| 526 | 26854135 |
US |
19 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 527 | 26854305 |
US |
2 | |
Ventricular tachycardia, Palpitations, Nasopharyngitis, Viral infection, |
||||
FOSTEMSAVIR TROMETHAMINE, |
||||
| 528 | 26854471 |
EU |
1 | 2 |
Respiratory syncytial virus bronchiolitis, Neonatal dyspnoea, Nasopharyngitis, Poor feeding infant, Vaccination failure, |
||||
NIRSEVIMAB, |
||||
| 529 | 26854509 |
CA |
64 | 2 |
Viral infection, Forced expiratory volume decreased, Middle insomnia, Weight increased, Asthma, Illness, Inappropriate schedule of product administration, Pulmonary function test decreased, Obstructive airways disorder, Reaction to excipient, Nasopharyngitis, Hypertonic bladder, Upper respiratory tract infection, Anaphylactic reaction, Product dose omission issue, Hypersensitivity, Mast cell activation syndrome, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ALBUTEROL SULFATE, |
||||
| 530 | 26854527 |
US |
14 | 1 |
Nasopharyngitis, Injection site pain, Inappropriate schedule of product administration, |
||||
DUPILUMAB, METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 531 | 26854563 |
CA |
58 | 2 |
COVID-19, Haemoglobin decreased, Pleural effusion, Pyrexia, Lymphadenopathy, Sinusitis, Condition aggravated, Nasopharyngitis, |
||||
METHOTREXATE, METHOTREXATE SODIUM, CELECOXIB, HYDROXYCHLOROQUINE, |
||||
| 532 | 26854571 |
CA |
6 | 2 |
Breast cancer, Nipple pain, Nasopharyngitis, Haemorrhage, Tonsillolith, Product dose omission issue, |
||||
INFLIXIMAB, INFLIXIMAB, |
||||
| 533 | 26854667 |
US |
79 | |
Somnolence, Nasopharyngitis, Cough, Diarrhoea, Vomiting, Drug ineffective, |
||||
NEMOLIZUMAB-ILTO, |
||||
| 534 | 26854773 |
US |
67 | 2 |
Incorrect dose administered, Nasopharyngitis, Nausea, Fatigue, |
||||
TIRZEPATIDE, WARFARIN, |
||||
| 535 | 26854804 |
US |
65 | 2 |
Device use error, Nasopharyngitis, Product communication issue, |
||||
EVOLOCUMAB, ATORVASTATIN CALCIUM, |
||||
| 536 | 26855175 |
CL |
8 | 2 |
Hip arthroplasty, Hypoacusis, Nasopharyngitis, |
||||
GOLIMUMAB, |
||||
| 537 | 26855392 |
26 | 1 | |
Nasopharyngitis, Product use in unapproved indication, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 538 | 26855792 |
JP |
68 | 2 |
Pulmonary hypertension, Pulmonary congestion, Nasopharyngitis, Infection, |
||||
SELEXIPAG, SILDENAFIL CITRATE, SILDENAFIL, MACITENTAN, |
||||
| 539 | 26855801 |
US |
14 | 1 |
Nasopharyngitis, Blood creatinine increased, Blood potassium increased, Cataract, |
||||
PREDNISONE, PREDNISONE, PEGCETACOPLAN, |
||||
| 540 | 26856008 |
US |
48 | 2 |
Pruritus, Nasopharyngitis, |
||||
DUPILUMAB, FEXOFENADINE HYDROCHLORIDE, |
||||
| 541 | 26856197 |
CA |
61 | 2 |
Pyrexia, Sneezing, Aphasia, Cystitis, Sinus congestion, Personality disorder, Dysarthria, Dysphagia, Pneumonia, Sensory loss, Adjustment disorder, Chest discomfort, Influenza, Motor dysfunction, Carotid artery thrombosis, Confusional state, Gangrene, Headache, Hemiplegia, Muscular weakness, Nasopharyngitis, Pain, Arthritis, Cerebrovascular accident, Influenza like illness, Malaise, Muscle spasticity, Psoriasis, Skin haemorrhage, Anxiety, Arterial occlusive disease, Cataract, Fall, Fatigue, Neurologic neglect syndrome, Respiratory tract congestion, Rhinorrhoea, Sinus disorder, Sinusitis, Coordination abnormal, Eating disorder, Hemiparesis, Skin exfoliation, Vomiting, Asthenia, Blood pressure increased, Cough, Rheumatoid arthritis, Affect lability, Angina pectoris, Nausea, Palpitations, Gastrointestinal disorder, Product use issue, |
||||
ZOLPIDEM TARTRATE, LISINOPRIL, PROCHLORPERAZINE MALEATE, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, CANDESARTAN CILEXETIL, AMLODIPINE BESYLATE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, PREDNISONE, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, IRBESARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, SITAGLIPTIN, BISOPROLOL FUMARATE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ALISKIREN HEMIFUMARATE, ALISKIREN HEMIFUMARATE, CALCIUM CARBONATE, ANTACID, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, ERGOCALCIFEROL, NAPROXEN, NAPROXEN SODIUM, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, DIMENHYDRINATE, DIMENHYDRINATE, DIMENHYDRINATE, IRBESARTAN, ATORVASTATIN CALCIUM, METHOTREXATE SODIUM, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MORPHINE SULFATE, ESOMEPRAZOLE MAGNESIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, RITUXIMAB, RITUXIMAB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED RELEASE, ESOMEPRAZOLE MAGNESIUM DIHYDRATE, ESOMEPRAZOLE MAGNESIUM DELAYED RELEASE CAPSULES, AMLODIPINE BESYLATE, IRBESARTAN, LEVOTHYROXINE SODIUM, CALCIUM CARBONATE, CANDESARTAN CILEXETIL, INSULIN LISPRO, METHYLPREDNISOLONE ACETATE, COAL TAR, LANOLIN, METHYLPREDNISOLONE ACETATE, ACITRETIN, INSULIN GLARGINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, HYDROCHLOROTHIAZIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYANOCOBALAMIN, TELMISARTAN, PANTOPRAZOLE, EZETIMIBE, PREGABALIN, DULOXETINE HYDROCHLORIDE, CANDESARTAN CILEXETIL, HYDROCHLOROTHIAZIDE, AMLODIPINE BESYLATE, LIDOCAINE HYDROCHLORIDE, LIDOCAINE HYDROCHLORIDE ANHYDROUS, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METHYLPREDNISOLONE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDICAINE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, IRBESARTAN, USTEKINUMAB, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ROSUVASTATIN, |
||||
| 542 | 26856233 |
US |
17 | 2 |
Feeling cold, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 543 | 26856237 |
US |
69 | 2 |
Eczema, Nasopharyngitis, Inappropriate schedule of product administration, Oropharyngeal pain, Nasal congestion, Pruritus, Paraesthesia, Skin exfoliation, Haemorrhage, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 544 | 26856767 |
US |
71 | 2 |
Skin papilloma, Nasopharyngitis, Tooth abscess, Constipation, Diarrhoea, |
||||
LENALIDOMIDE, |
||||
| 545 | 26856968 |
CN |
80 | 1 |
Nasopharyngitis, Cough, Chest discomfort, Dyspnoea, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 546 | 26857148 |
US |
2 | |
Nasopharyngitis, Cough, Respiratory tract congestion, |
||||
DUPILUMAB, |
||||
| 547 | 26857184 |
US |
66 | 2 |
Dyspnoea, Psoriasis, Dizziness, Eye infection, Feeling hot, Nasopharyngitis, Herpes virus infection, Speech disorder, Sitting disability, Urinary tract infection, Oropharyngeal pain, Asthenia, Eye irritation, Anxiety, Infection, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 548 | 26846759 |
EU |
8 | 2 |
Lower respiratory tract infection, Nasopharyngitis, |
||||
GOLIMUMAB, |
||||
| 549 | 26846876 |
US |
2 | |
Back pain, Nasopharyngitis, |
||||
DARATUMUMAB, |
||||
| 550 | 26846928 |
US |
51 | 1 |
Nasal congestion, Dyspnoea, Cough, Chest discomfort, Productive cough, Pyrexia, Pulmonary mass, Weight abnormal, Tooth extraction, Nasopharyngitis, |
||||
DUPILUMAB, PREDNISONE, |
||||
| 551 | 26847031 |
JP |
65 | |
Toxic skin eruption, Erythema, Nasopharyngitis, |
||||
BETAMETHASONE DIPROPIONATE, |
||||
| 552 | 26847271 |
US |
63 | 2 |
Pain, Nasopharyngitis, Cough, |
||||
ABATACEPT, |
||||
| 553 | 26847548 |
US |
96 | 2 |
Nasopharyngitis, |
||||
VIBEGRON, |
||||
| 554 | 26847885 |
US |
73 | 2 |
Nasopharyngitis, |
||||
RILZABRUTINIB, HYDROCHLOROTHIAZIDE, LISINOPRIL, CALCIUM CARBONATE, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, FAMOTITINE, FAMOTIDINE, |
||||
| 555 | 26847900 |
US |
53 | 1 |
Post procedural haemorrhage, Postoperative wound complication, Post procedural swelling, Nasopharyngitis, Taste disorder, Blood pressure increased, Haemorrhage, Tremor, Fear of injection, Poor venous access, |
||||
ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC-VWF-XTEN FUSION PROTEIN-EHTL, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 556 | 26848120 |
US |
75 | 1 |
Nasopharyngitis, Frequent bowel movements, Cough, Abdominal discomfort, |
||||
ORAL SEMAGLUTIDE, |
||||
| 557 | 26848137 |
US |
48 | 2 |
Influenza, Nasopharyngitis, |
||||
TRALOKINUMAB-LDRM, |
||||
| 558 | 26848231 |
US |
5 | 2 |
Nasopharyngitis, Pyrexia, Cough, Therapeutic product effect decreased, |
||||
DUPILUMAB, |
||||
| 559 | 26848436 |
US |
1 | |
Hospitalisation, Nasopharyngitis, |
||||
CILTACABTAGENE AUTOLEUCEL, |
||||
| 560 | 26849044 |
CA |
28 | 2 |
Weight increased, Feeling abnormal, Face oedema, Self esteem decreased, Urticaria, Illness, Discomfort, Nasopharyngitis, Off label use, Stress, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, PREDNISONE, PREDNISONE, DIPHENHYDRAMINE HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, PREDNISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, HYDROCORTISONE CREAM 1/2%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, |
||||
| 561 | 26849942 |
JP |
1 | |
Interstitial lung disease, Malaise, Chromaturia, Decreased appetite, Urine output decreased, Pyrexia, Nasopharyngitis, Arthralgia, Diarrhoea, Liver function test increased, |
||||
AVACOPAN, NINTEDANIB, |
||||
| 562 | 26849953 |
CN |
||
Haematochezia, Product packaging quantity issue, Oral mucosal blistering, Mouth ulceration, Parotid gland enlargement, Vomiting, Rhinorrhoea, Nasopharyngitis, Pain, |
||||
SELUMETINIB, |
||||
| 563 | 26850031 |
US |
65 | 2 |
Formication, Nasopharyngitis, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 564 | 26850265 |
EU |
51 | 2 |
Malignant neoplasm progression, Pyrexia, Pain, Malaise, Chills, Abdominal distension, Immune system disorder, Gastrointestinal disorder, Hypersomnia, Dry mouth, Fatigue, Nausea, Headache, Diarrhoea, Decreased appetite, Nasopharyngitis, Drug ineffective, |
||||
ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, EXEMESTANE, EXEMESTANE, EXEMESTANE, EXEMESTANE, |
||||
| 565 | 26850312 |
CA |
69 | 2 |
Malaise, Nasopharyngitis, Nausea, Vomiting, Depression, Pain, Trismus, Rheumatoid arthritis, Upper-airway cough syndrome, Sinus congestion, Sneezing, Pain in extremity, Inappropriate schedule of product administration, |
||||
METHOTREXATE, METHOTREXATE SODIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, PREDNISONE, PREDNISONE, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, DESOXIMETASONE, FOLIC ACID, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, RANITIDINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, ROSUVASTATIN CALCIUM, TIOTROPIUM BROMIDE, |
||||
| 566 | 26850313 |
US |
61 | 2 |
Intentional product misuse, Pain in extremity, Musculoskeletal stiffness, Glaucoma, Therapeutic response unexpected, Abdominal distension, Constipation, Osteoporosis, Nasopharyngitis, Influenza, Hypersensitivity, Vertigo, Pain, Muscle spasms, Muscle strain, |
||||
TOFACITINIB, TOFACITINIB, ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, MELOXICAM, |
||||
| 567 | 26850446 |
US |
29 | 2 |
Migraine, Nasopharyngitis, Device difficult to use, Drug dose omission by device, |
||||
ERENUMAB-AOOE, RIZATRIPTAN, RIMEGEPANT SULFATE, |
||||
| 568 | 26850605 |
CA |
43 | 2 |
Confusional state, Decreased appetite, Deep vein thrombosis postoperative, Delirium, Depression, Diarrhoea, Discomfort, Dislocation of vertebra, Dizziness, Drug hypersensitivity, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Facet joint syndrome, Gait disturbance, Gait inability, Gastrointestinal disorder, General physical health deterioration, Glossodynia, Grip strength decreased, Liver disorder, Lower limb fracture, Lung disorder, Muscle injury, Muscle spasms, Musculoskeletal pain, Musculoskeletal stiffness, Nasopharyngitis, Nausea, Night sweats, Obesity, Oedema, Oedema peripheral, Osteoarthritis, Pain, Pericarditis, Drug intolerance, Paraesthesia, Pemphigus, Peripheral swelling, Peripheral venous disease, Psoriatic arthropathy, Pyrexia, Rash, Rheumatoid arthritis, Rheumatoid factor positive, Sciatica, Sinusitis, Sleep disorder, Sleep disorder due to general medical condition, insomnia type, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight decreased, Weight increased, Wheezing, Wound infection, Contraindicated product administered, Off label use, Product use in unapproved indication, |
||||
PREGABALIN, APREMILAST, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CALCIUM, CALCIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RISEDRONATE SODIUM, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, PREDNISONE, PREDNISONE, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, INFLIXIMAB, INFLIXIMAB, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM 220MG, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, APREMILAST, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE TABLETS, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFAMETHOXAZOLE AND TRIMETHOPRIM, TOFACITINIB CITRATE, TOFACITINIB CITRATE, VITAMIN C, ERGOCALCIFEROL, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
| 569 | 26850812 |
US |
2 | |
Nasopharyngitis, Feeling jittery, Palpitations, Viral infection, |
||||
FLUTICASONE FUROATE, FLUTICASONE FUROATE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, |
||||
| 570 | 26850813 |
US |
||
Immunodeficiency, Systemic lupus erythematosus, Infection, Nasopharyngitis, Influenza, Inappropriate schedule of product administration, |
||||
BELIMUMAB, BELIMUMAB, PREDNISONE, |
||||
| 571 | 26852115 |
CA |
40 | 2 |
Rheumatoid arthritis, Nasopharyngitis, Influenza like illness, Malaise, Off label use, |
||||
GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, |
||||
| 572 | 26845932 |
CA |
2 | |
Asthma, Nasopharyngitis, |
||||
MEPOLIZUMAB, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, ALBUTEROL SULFATE, |
||||
| 573 | 26845984 |
US |
78 | 2 |
Nasopharyngitis, Multiple allergies, Bronchitis, |
||||
DULAGLUTIDE, |
||||
| 574 | 26846004 |
US |
45 | 1 |
Sinusitis, Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 575 | 26846056 |
US |
67 | 1 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 576 | 26846193 |
US |
2 | |
Eye disorder, Oropharyngeal discomfort, Nasopharyngitis, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, ALBUTEROL SULFATE, ALBUTEROL, BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, INSULIN GLARGINE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MONTELUKAST, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, SIMVASTATIN, REVEFENACIN, |
||||
| 577 | 26846400 |
US |
37 | 2 |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 578 | 26846492 |
US |
49 | 2 |
Nasopharyngitis, Contusion, |
||||
EVOLOCUMAB, |
||||
| 579 | 26846592 |
CL |
63 | 1 |
Nephrolithiasis, Nasopharyngitis, Urinary tract infection, Haematuria, Prostatomegaly, |
||||
GUSELKUMAB, |
||||
| 580 | 26844972 |
US |
26 | 2 |
Middle insomnia, Feeling abnormal, Decreased appetite, Poor quality sleep, Nasopharyngitis, Somnolence, Fatigue, Abdominal discomfort, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, SODIUM OXYBATE, PITOLISANT HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, BIOTIN, PHYTONADIONE, SPIRONOLACTONE, |
||||
| 581 | 26845041 |
CA |
43 | 2 |
Type 2 diabetes mellitus, Alopecia, Condition aggravated, Hand deformity, Hypoaesthesia, Muscle injury, Osteoarthritis, Pemphigus, Pericarditis, Stomatitis, Arthropathy, Fatigue, Helicobacter infection, Hypertension, Inflammation, Lip dry, Live birth, Liver injury, Lower respiratory tract infection, Maternal exposure during pregnancy, Mobility decreased, Musculoskeletal pain, Nail disorder, Nasopharyngitis, Obesity, Psoriatic arthropathy, Rheumatoid arthritis, Swelling, Systemic lupus erythematosus, Wound infection, Urticaria, Wheezing, Abdominal pain, Anti-cyclic citrullinated peptide antibody positive, Anxiety, Asthma, Autoimmune disorder, C-reactive protein abnormal, |
||||
ERENUMAB-AOOE, ERENUMAB-AOOE, ERENUMAB-AOOE, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, DICLOFENAC SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, CANDESARTAN, CANDESARTAN, CANDESARTAN, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, OXYCODONE, OXYCODONE, OXYCODONE, OXYCODONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREGABALIN, PREGABALIN, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, CALCIUM CARBONATE, CALCIUM CARBONATE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, BOTULINUM TOXIN TYPE A, BOTULINUM TOXIN TYPE A, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, BUPRENORPHINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, LAMOTRIGINE, LAMOTRIGINE, PYRIDOXINE HYDROCHLORIDE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, SARILUMAB, SARILUMAB, SARILUMAB, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, ACETAMINOPHEN, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, ERGOCALCIFEROL, CALCIUM CARBONATE, CALCIUM CARBONATE, ERGOCALCIFEROL, DEXPANTHENOL, MAGNESIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PHENYLEPHRINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LORAZEPAM, CYANOCOBALAMIN, ICOSAPENT ETHYL, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN TABLET, FILM COATED, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, LANSOPRAZOLE, |
||||
| 582 | 26845123 |
US |
60 | 2 |
Nasopharyngitis, Psoriasis, Eczema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 583 | 26845126 |
US |
2 | |
Nasopharyngitis, |
||||
DUPILUMAB, |
||||
| 584 | 26845183 |
US |
2 | |
Cough, Hunger, Nasopharyngitis, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 585 | 26845312 |
US |
45 | 1 |
Toothache, Upper respiratory tract infection, Nasopharyngitis, Nasal congestion, Oropharyngeal pain, Eczema, |
||||
DUPILUMAB, DUPILUMAB, NAPROXEN SODIUM, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, GUAIFENESIN, NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE, PREDNISONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 586 | 26845322 |
US |
40 | 1 |
Asthma, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 587 | 26845848 |
US |
75 | 1 |
Extra dose administered, Nasopharyngitis, |
||||
DULAGLUTIDE, DULAGLUTIDE, |
||||
| 588 | 26839940 |
US |
76 | 2 |
Pneumonia, Pleural effusion, Nasopharyngitis, Bronchitis, Haemoptysis, Product dose omission issue, |
||||
MEPOLIZUMAB, |
||||
| 589 | 26839998 |
US |
49 | 2 |
Paranasal sinus inflammation, Nasopharyngitis, Paranasal sinus discomfort, Product container issue, Hypersensitivity, Medication error, |
||||
ALECTINIB HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 590 | 26840051 |
US |
67 | 2 |
Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, PREDNISONE, |
||||
| 591 | 26840068 |
US |
2 | |
Fatigue, Nasopharyngitis, |
||||
RISANKIZUMAB-RZAA, |
||||
| 592 | 26840073 |
US |
89 | |
Nasopharyngitis, Incorrect dose administered, |
||||
NEMOLIZUMAB-ILTO, NEMOLIZUMAB-ILTO, ISOSORBIDE MONONITRATE, ROSUVASTATIN CALCIUM, CARVEDILOL, FUROSEMIDE, FERROUS SULFATE, |
||||
| 593 | 26840197 |
CA |
24 | 2 |
Defaecation urgency, Infusion related reaction, Respiratory tract congestion, Cough, Nasopharyngitis, |
||||
ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, ADALIMUMAB, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB-FKJP, IRON SUCROSE, |
||||
| 594 | 26840220 |
US |
2 | |
Nasopharyngitis, Diarrhoea, Somnolence, Illness, Hyperhidrosis, |
||||
RAVULIZUMAB, |
||||
| 595 | 26840276 |
US |
2 | |
Illness, Nasopharyngitis, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 596 | 26840821 |
US |
58 | 2 |
Nasopharyngitis, Chronic obstructive pulmonary disease, |
||||
DUPILUMAB, |
||||
| 597 | 26841051 |
US |
70 | |
Nasopharyngitis, |
||||
SIPULEUCEL-T, SIPULEUCEL-T, |
||||
| 598 | 26841170 |
US |
70 | |
Nasopharyngitis, |
||||
SIPULEUCEL-T, SIPULEUCEL-T, LEUPROLIDE ACETATE, ABIRATERONE ACETATE, ABIRATERONE, PREDNISONE, LOSARTAN, ALLOPURINOL, |
||||
| 599 | 26841200 |
US |
63 | |
Infusion related reaction, Nasopharyngitis, |
||||
SIPULEUCEL-T, AMLODIPINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FAMOTIDINE, |
||||
| 600 | 26841331 |
US |
76 | |
White blood cell count decreased, Haematocrit decreased, Red blood cell count decreased, Haemoglobin decreased, Nasopharyngitis, Product dose omission issue, |
||||
LENALIDOMIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-07-30